Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2875 of 3546 entries
View as:

Immunogenicity, Safety & Reactogenicity of GSK Vaccine Tritanrix™-HepB/Hib2.5 Compared to GSK Vaccine Tritanrix™-HepB/Hiberix™

Phase: N/A Priority: Normal
NCT ID: NCT01061541 Org: User:
Start: 08/31/03 End: 08/31/04 Due: 08/31/05

A Study To Assess GW677954 Used In Combination With Insulin In Subjects Who Have Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00437164 Org: User:
Start: 09/30/06 End: 11/30/06 Due: 11/30/07

Study of Inhaler Device Attributes Investigating Critical and Overall Errors, Ease of Use, and Preference Between a Number of Inhaler Devices

Phase: N/A Priority: Normal
NCT ID: NCT02184624 Org: User:
Start: 08/28/14 End: 07/31/15 Due: 07/31/16

Tucaresol As Add-On To HAART (Highly Active Antiretroviral Therapy) In Chronic HIV-1 Infected Adults

Phase: N/A Priority: Normal
NCT ID: NCT00343941 Org: User:
Start: 11/30/04 End: - Due: -

A Study to Evaluate the Effects of GW679769 on Sleep and Cognitive Function in Subjects With Primary Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT00650871 Org: User:
Start: 07/30/04 End: 08/30/05 Due: 08/30/06

Clinical Evaluation of BW430C in Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT00395694 Org: User:
Start: 08/07/06 End: 03/26/09 Due: 03/26/10

To Evaluate Plasma and Pulmonary Pharmacokinetics of GSK2140944

Phase: N/A Priority: Normal
NCT ID: NCT01934205 Org: User:
Start: 09/25/13 End: 12/21/13 Due: 12/21/14

The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00511823 Org: User:
Start: 07/23/07 End: 09/21/07 Due: 09/21/08

Study of Long Term Immune Responses and Safety of the GSK Herpes Zoster Vaccine in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01295320 Org: User:
Start: 02/28/11 End: 06/20/13 Due: 06/20/14

Evaluation of Fondaparinux in Patients With a Heart Rhythm Disturbance Who Undergo Restoration of Normal Heart Rhythm

Phase: N/A Priority: Normal
NCT ID: NCT00911300 Org: User:
Start: 08/31/09 End: 09/30/11 Due: 09/30/12

Proof of Concept Anti-ageing Clinical Study in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03180645 Org: User:
Start: 03/20/17 End: 04/21/17 Due: 04/21/18

Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00429299 Org: User:
Start: 08/31/06 End: 06/30/12 Due: 06/30/13

A Study Conducted in Healthy Subjects to Demonstrate Bioequivalence Between Ropinirole Prolonged Release Tablets Manufactured at Crawley and Aranda

Phase: N/A Priority: Normal
NCT ID: NCT01371682 Org: User:
Start: 09/18/09 End: 12/02/09 Due: 12/02/10

Treatment With Pazopanib for Neoadjuvant Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00849472 Org: User:
Start: 07/31/09 End: 04/30/13 Due: 04/30/14

Safety Study Using GSK233705 And Tiotropium In Patients With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT00279019 Org: User:
Start: 12/12/05 End: 06/13/06 Due: 06/13/07

SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fed Admin

Phase: N/A Priority: Normal
NCT ID: NCT01330303 Org: User:
Start: 12/08/09 End: 12/22/09 Due: 12/22/10

Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT00134719 Org: User:
Start: 04/11/05 End: 02/21/07 Due: 02/21/08

A Study to Test if the Vaccine is Working Well in Chronic Obstructive Pulmonary Disease (COPD) Patients Aged 40 to 80 Years Old to Reduce Episodes of Worsening Symptoms and to Gather Further Information on Safety and Immune Response.

Phase: N/A Priority: Normal
NCT ID: NCT03281876 Org: User:
Start: 11/27/17 End: 03/26/20 Due: 03/26/21

A Phase I Rheumatoid Arthritis Study in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00539760 Org: User:
Start: 09/05/07 End: 04/05/08 Due: 04/05/09

A Study to Characterize Diclofenac's Plasma and Knee Exposure After Application of Diclofenac Gel to the Knee of Subjects With Osteoarthritis That Have a Scheduled Arthroplasty

Phase: N/A Priority: Normal
NCT ID: NCT03497039 Org: User:
Start: 07/19/18 End: 03/01/19 Due: 03/01/20

Risk Management Plan (RMP) Survey for Purchasers of Alli® (60 mg Orlistat) in the European Union.

Phase: N/A Priority: Normal
NCT ID: NCT02141230 Org: User:
Start: 12/31/15 End: 02/29/16 Due: 02/28/17

Assess the Immunogenicity & Safety of 2 Doses of Oral Live Attenuated Human Rota(HRV)Vaccine in Healthy Infants in India

Phase: N/A Priority: Normal
NCT ID: NCT00289172 Org: User:
Start: 02/10/06 End: 09/08/06 Due: 09/08/07

Patient Preference Study of Fluticasone Furoate and Mometasone Furoate Nasal Sprays

Phase: N/A Priority: Normal
NCT ID: NCT02397915 Org: User:
Start: 03/26/15 End: 06/08/15 Due: 06/08/16

A Methodology Study to Assess Muscle Damage After Eccentric Exercise

Phase: N/A Priority: Normal
NCT ID: NCT02014662 Org: User:
Start: 01/14/14 End: 07/02/14 Due: 07/02/15

Odiparcil For The Prevention Of Venous Thromboembolism

Phase: N/A Priority: Normal
NCT ID: NCT00244725 Org: User:
Start: 09/30/05 End: 09/30/06 Due: 09/30/07